StockClub

BBIO

BBIOBridgeBio Pharma, Inc.$ --
BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc.

BBIO

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
195M USD
YoY +66.8%
Operating Income
-106M USD
YoY -1.5%
Net Income
-164M USD
YoY +2.0%
EPS
-0.84$
YoY +4.5%

Revenue

$194.5M
FY2024 Q2$213.3M
$213.3M
Q2
FY2024 Q3$216M
$216M
Q3
FY2024 Q4$221.9M
$221.9M
Q4
FY2025 Q1$116.6M
$116.6M
Q1
FY2025 Q2$227.2M
$227.2M
Q2
FY2025 Q3$347.9M
$347.9M
Q3
FY2025 Q4$502.1M
$502.1M
Q4
FY2026 Q1$194.5M
$194.5M
Q1
Actual
+$77.9M (+66.8%)

Net Income

$-164M
FY2024 Q2$-108.7M
$-108.7M
Q2
FY2024 Q3$-270.7M
$-270.7M
Q3
FY2024 Q4$-535.8M
$-535.8M
Q4
FY2025 Q1$-167.4M
$-167.4M
Q1
FY2025 Q2$-349.3M
$-349.3M
Q2
FY2025 Q3$-532.1M
$-532.1M
Q3
FY2025 Q4$-729.3M
$-729.3M
Q4
FY2026 Q1$-164M
$-164M
Q1
Actual
+$3.4M (+2.0%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$8.2M
Est:$22.5M
FY2020MISS
$8.2M
FY2021MISS
Actual:$69.7M
Est:$78.3M
FY2021MISS
$69.7M
FY2022MISS
Actual:$77.6M
Est:$82.7M
FY2022MISS
$77.6M
FY2023MISS
Actual:$9.3M
Est:$219.1M
FY2023MISS
$9.3M
FY2024BEAT
Actual:$221.9M
Est:$219.1M
FY2024BEAT
$221.9M
FY2025BEAT
Actual:$502.1M
Est:$496.3M
FY2025BEAT
$502.1M

Analyst Estimates